🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

GlaxoSmithKline Pharmaceuticals Limited GLAXO NIFTY_MIDNSEPHARMA

Healthcare · Drug Manufacturers - General · India
https://india-pharma.gsk.com

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella; and Shingrix for prevention of herpes zoster and post-herpetic neuralgia. It also provides specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and Trelegy Ellipta for treating chronic obstructive pulmonary disease. In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, an oral antibiotic to treat bacterial infections; CobadexCZS to treat mineral and vitamins deficiency states; Flutivate, a skin cream for adults, children, and infants; Tenovate to treat inflammatory and pruritic manifestations of steroid responsive dermatosis; CALPOL to treat mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment of specific bacterial skin infections; BETNOVATE for skin conditions; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin associated with redness and itch. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. The company was incorporated in 1924 and is based in Mumbai, India. GlaxoSmithKline Pharmaceuticals Limited operates as a subsidiary of GSK plc.

READ MORE ›
₹2,210.20
-31.39% 1Y

Market & Price

Market Cap
₹37,442.12 Cr
Current Price
₹2,210.20
High / Low (52W)
₹3,466.20 / ₹2,210.20
Beta
0.10

Valuation

Stock P/E
36.76
Industry PE
37.60
Forward P/E
28.60
PEG Ratio
-
Book Value
₹100.81
Price to Book
21.92
P/S
9.80
EV/EBITDA
26.50
Dividend Yield
2.58%

Profitability & Returns

ROCE
55.36%
ROE
49.11%
ROA
18.42%
Profit Margin
27.11%
Op Margin
33.94%
EPS (Latest Qtr)
₹16.40
EPS (TTM)
₹60.12

Balance Sheet & Liquidity

Debt/Equity
1.47
Quick Ratio
1.72
Current Ratio
2.03
Debt
₹33.27 Cr
Total Assets
₹4,323.87 Cr
Current Assets
₹3,607.05 Cr
Working Capital
₹1,827.94 Cr

Ownership

Promoter Holding
75.64%
Chg in Prom Hold
-
FII / Inst Holding
8.52%
Chg in FII Hold
-0.00%

Financial Snapshot

Enterprise Value
₹34,698.01 Cr
Total Revenue (TTM)
₹3,821.67 Cr
EBITDA
₹1,309.20 Cr
Free Cash Flow
₹739.17 Cr
Operating Cash Flow
₹903.30 Cr
Shares Outstanding
₹16.94 Cr
Gross Margin
64.65%
Payout Ratio
69.87%

Growth (CAGR)

Revenue 5Y
5.81%
Profit 5Y
19.26%
Revenue (YoY)
2.10%
Earnings (YoY)
5.70%

PROS

  • Strong return on equity of 49.1%.
  • Healthy ROCE of 55.4%.
  • Excellent profit margin of 27.1%.
  • Profit CAGR of 19.3% over 5 years.
  • Attractive dividend yield of 2.58%.
  • Generates positive free cash flow.

CONS

  • Trading 36.2% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 GLAXO GlaxoSmithKline Pharmaceuticals Limited NIFTY_MIDNSEPHARMA 2,210.20 36.76 ₹37,442.12 Cr 2.58% 55.36% 49.11% 5.81% 19.26%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,799.20 37.59 ₹4.32 L Cr 0.92% 17.94% 14.72% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,667.00 68.97 ₹1.77 L Cr 0.45% 18.96% 16.19% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,410.80 68.96 ₹1.49 L Cr 0.86% 9.06% 16.98% 13.27% 20.21%
5 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,401.00 29.16 ₹1.13 L Cr 0.93% 14.88% 11.74% 7.23% 11.45%
6 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,303.50 25.90 ₹1.09 L Cr 0.61% 14.00% 11.83% 10.96% -2.35%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,077.70 21.51 ₹1.08 L Cr 0.09% 19.24% 18.32% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,267.70 19.49 ₹1.04 L Cr 0.53% 28.42% 26.91% 19.10% 131.46%
9 MANKIND Mankind Pharma Limited NIFTY_MIDNSEPHARMA 2,375.60 51.29 ₹98,090.71 Cr 0.08% 13.78% 12.45% 17.73% 14.28%
Ad space

Quarterly Results

Figures in INR.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Dec 2025Mar 2026
Revenue -949.42 Cr974.37 Cr805.17 Cr1,041.26 Cr995.30 Cr
Cost of Revenue -359.16 Cr351.94 Cr287.71 Cr363.82 Cr344.00 Cr
Gross Profit -590.26 Cr622.43 Cr517.46 Cr677.44 Cr651.30 Cr
Operating Expenses -317.14 Cr303.96 Cr281.78 Cr326.42 Cr313.54 Cr
Operating Income -273.12 Cr318.47 Cr235.68 Cr351.02 Cr337.76 Cr
EBITDA -326.99 Cr373.87 Cr294.92 Cr421.44 Cr386.88 Cr
Interest Expense -9.00 L58.00 L42.00 L1.19 Cr61.00 L
Pretax Income -308.10 Cr358.57 Cr278.98 Cr399.93 Cr373.10 Cr
Tax Provision -78.22 Cr95.70 Cr73.97 Cr104.31 Cr95.24 Cr
Net Income -229.88 Cr262.87 Cr205.01 Cr295.62 Cr277.86 Cr
Diluted EPS -13.5715.5212.1017.4516.40

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -3,226.38 Cr3,441.77 Cr3,749.21 Cr3,821.67 Cr
Cost of Revenue -1,358.72 Cr1,419.85 Cr1,390.86 Cr1,351.06 Cr
Gross Profit -1,867.66 Cr2,021.92 Cr2,358.35 Cr2,470.61 Cr
Operating Expenses -1,119.23 Cr1,183.44 Cr1,247.78 Cr1,227.85 Cr
Operating Income -748.43 Cr838.49 Cr1,110.57 Cr1,242.76 Cr
EBITDA -903.98 Cr887.67 Cr1,327.98 Cr1,475.18 Cr
Interest Expense -1.81 Cr1.80 Cr1.31 Cr2.73 Cr
Pretax Income -836.40 Cr816.19 Cr1,259.88 Cr1,406.01 Cr
Tax Provision -228.76 Cr226.23 Cr332.30 Cr370.03 Cr
Net Income -610.69 Cr589.96 Cr927.58 Cr1,035.98 Cr
Diluted EPS 100.0436.0534.8354.52-

Compounded Sales Growth

5 Years:5.81%
1 Year:2.10%

Compounded Profit Growth

5 Years:19.26%
1 Year:5.70%

Stock Price Performance

1 Year:-31.39%
6 Months:-10.77%
3 Months:-16.24%
1 Month:-6.61%

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -3,326.58 Cr3,556.62 Cr4,108.07 Cr4,323.87 Cr
Current Assets -2,494.26 Cr2,798.42 Cr3,409.88 Cr3,607.05 Cr
Cash & Equivalents -34.94 Cr64.17 Cr538.85 Cr1,102.05 Cr
Inventory -459.97 Cr525.05 Cr481.74 Cr457.55 Cr
Receivables -192.38 Cr222.06 Cr292.55 Cr273.11 Cr
Total Liabilities -1,585.31 Cr1,778.98 Cr2,156.75 Cr2,056.45 Cr
Current Liabilities -1,326.37 Cr1,524.95 Cr1,905.15 Cr1,779.11 Cr
Long Term Debt -----
Total Debt -15.54 Cr18.66 Cr9.95 Cr33.27 Cr
Total Equity -1,741.27 Cr1,777.64 Cr1,951.31 Cr2,267.42 Cr
Shares Outstanding -16.94 Cr16.94 Cr16.94 Cr16.94 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -484.23 Cr582.02 Cr1,289.91 Cr903.30 Cr
Investing Cash Flow -807.85 Cr8.71 Cr-45.81 Cr396.98 Cr
Financing Cash Flow --1,543.32 Cr-561.50 Cr-769.42 Cr-737.08 Cr
Capital Expenditure --44.04 Cr-31.22 Cr-24.72 Cr-55.28 Cr
Free Cash Flow -440.19 Cr550.79 Cr1,265.19 Cr848.02 Cr
Net Change in Cash --251.25 Cr29.23 Cr474.68 Cr563.20 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -57.9%58.7%62.9%64.6%
Operating Margin % -23.2%24.4%29.6%32.5%
Net Margin % -18.9%17.1%24.7%27.1%
ROE % -35.1%33.2%47.5%45.7%
ROCE % -37.4%41.3%50.4%48.8%

Shareholding Pattern

Insiders
75.64%
Institutions
8.52%
Public Float
34.96%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for GLAXO

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks